Renishaw (RSW) Downgraded by Numis Securities to “Hold”
Renishaw (LON:RSW) was downgraded by stock analysts at Numis Securities to a “hold” rating in a report issued on Tuesday. They presently have a GBX 5,200 ($69.99) price target on the stock. Numis Securities’ target price suggests a potential upside of 1.46% from the stock’s current price.
RSW has been the topic of a number of other research reports. Deutsche Bank reiterated a “sell” rating and issued a GBX 3,630 ($48.86) target price on shares of Renishaw in a research note on Monday, October 23rd. Peel Hunt lowered Renishaw to a “reduce” rating and set a GBX 4,200 ($56.53) target price on the stock. in a research note on Tuesday, October 31st. Citigroup reiterated a “neutral” rating and issued a GBX 470 ($6.33) target price on shares of Renishaw in a research note on Monday, October 30th. Barclays increased their target price on Renishaw from GBX 2,620 ($35.26) to GBX 3,880 ($52.22) and gave the stock an “underweight” rating in a research note on Thursday, August 17th. Finally, Investec reiterated a “hold” rating on shares of Renishaw in a research note on Friday, August 25th. Three investment analysts have rated the stock with a sell rating and five have assigned a hold rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of GBX 3,432.57 ($46.20).
Renishaw (LON:RSW) traded down GBX 40 ($0.54) during mid-day trading on Tuesday, reaching GBX 5,125 ($68.98). The company’s stock had a trading volume of 101,274 shares, compared to its average volume of 94,128. Renishaw has a twelve month low of GBX 2,355 ($31.70) and a twelve month high of GBX 5,635 ($75.84).
Renishaw plc is a metrology company. The Company operates through two segments: metrology and healthcare. The Company’s metrology products are used in the fields of industrial automation and motion systems. The healthcare products include engineering solutions for stereotactic neurosurgery, diagnosis of infectious diseases, analytical tools that identify and characterize the chemistry and structure of materials, supply of implants to hospitals and specialist design centers for craniomaxillofacial surgery, and products and services that allow dental laboratories to manufacture dental restorations.
Receive News & Ratings for Renishaw plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Renishaw plc and related companies with MarketBeat.com's FREE daily email newsletter.